ORDER BY 4PM FOR SAME-DAY DISPATCH

Illustrative HPLC chromatogram

HPLC Purity vs Net Peptide Content

The Research Edit 5 min read By the OP Labs editorial team

HPLC purity, net peptide content and identity are three different measurements. What each one tells you, where it stops, and what it means for the concentration of your stock solution.

Illustrative HPLC chromatogram
Illustrative — an HPLC chromatogram. Purity is read from the peaks; peptide content is not. OP Labs · Research

Chromatographic purity says nothing about how much of the powder is peptide. In a published purity assignment for an angiotensin II reference material, the TFA counter-ion alone made up nearly 25% of the mass, and the assigned peptide content was 691 ± 9 mg/g (k = 2) (Melanson et al., 2018).

Purity, net peptide content and identity are separate measurements. Conflate them and the error carries into every concentration you calculate.

Three numbers, three questions

MeasurementQuestion it answersWhat it cannot see
HPLC purity (UV area %)What share of the detected peptide material is the target?Counter-ions, salts, and impurities co-eluting with the main peak
Net peptide contentWhat share of the powder’s mass is peptide?Related peptide impurities, unless corrected for
Mass spectrometryDoes the main component have the expected mass?Isomers and residue order

What HPLC purity measures

Purity is the main peak’s share of total integrated UV area, typically by reversed-phase HPLC at 210–220 nm under acidic, TFA-containing conditions (Mant et al., 2007). Two limits follow.

  • It is relative. Counter-ions and inorganic salts don’t appear as peptide peaks, so they never enter the calculation. A clean chromatogram says nothing about how much of the powder is peptide.
  • It depends on the method. Resolution changes with gradient steepness, and a shallow gradient can resolve closely related synthetic impurities from the main peak (Mant et al., 2007). Run a steeper generic gradient and they may sit underneath it. Two “99%” results from different methods are not the same claim.

The impurities HPLC is there to find

Synthetic peptides carry by-products of their own synthesis and storage, and most are close relatives of the target.

ImpurityOriginMass shift vs target
Deletion sequenceIncomplete coupling; generated at each residue added (Mascagni, 1999)Minus one residue
AspartimideCyclisation at aspartate during Fmoc synthesis, notably at Asp-Gly (Mergler et al., 2003)−18 Da
IsoaspartateSuccinimide-linked isomerisation at Asp (Geiger & Clarke, 1987)0 Da
D-residueRacemisation through the same succinimide (Geiger & Clarke, 1987)0 Da
DeamidationAsn converted to Asp or isoAsp (Geiger & Clarke, 1987)+0.98 Da
Methionine sulfoxideOxidation; Met and Cys are particularly sensitive (Stadtman & Levine, 2003)+16 Da

Mass shifts are monoisotopic, calculated from atomic masses.

Three of those rows are the problem. Isoaspartate and D-residues change no mass at all, and a +0.98 Da shift sits inside the isotope envelope at low resolution. A mass check will not reliably catch them. Chromatographic separation can, if the method resolves them.

Net peptide content: the number that sets your concentration

Peptides made by solid-phase synthesis and purified by RP-HPLC are usually isolated as trifluoroacetate salts. TFA cleaves the peptide from the resin and, typically at 0.1% (v/v), is the ion-pairing acid in purification. Some ends up bound to basic groups; some is simply adsorbed in the lyophilisate (Sikora et al., 2020).

Net peptide content is measured, not derived from purity. The conventional reference method is amino acid analysis after hydrolysis, for example by isotope-dilution LC-MS/MS. Quantitative NMR measures the intact peptide and avoids hydrolysis bias. Both need correcting for related peptide impurities (Melanson et al., 2018).

Net peptide content pairs with the free-peptide MW. A salt-form MW already includes the counter-ion, so applying both corrections counts it twice.

The counter-ion is not inert

TFA may interfere with physicochemical characterisation as well as with cell-based work, and can inhibit cell proliferation (Sikora et al., 2020). In cell work, a counter-ion effect can be mistaken for a peptide effect.

Exchange works, with caveats. Repeated lyophilisation from HCl is slow, can be incomplete and risks hydrolysis; ion-exchange resins and preparative HPLC with a different mobile-phase acid are among the alternatives. Residual TFA can be measured by ion chromatography, described as the technique of first choice, or by ¹⁹F NMR, where TFA gives a singlet near −75 ppm (Sikora et al., 2020).

From powder to molar concentration

Concentration = (mass weighed × net peptide content) ÷ (free-peptide MW × volume)

Example: 5.0 mg at 80% net peptide content and a free-peptide MW of 1,000 g/mol, made up to 1.0 mL, gives 4.0 mM. The weighed mass alone says 5.0 mM, putting every downstream concentration 25% too high. (Round numbers; substitute your lot’s measured values.)

If a certificate gives no net peptide content, estimate it by mass balance from the purity, counter-ion and water results. Peptide COA Data: Methods and Their Limits sets out the calculation. Anything not measured still counts as peptide, so treat the estimate as an upper limit.

If the sequence contains tryptophan or tyrosine, absorbance at 280 nm gives an independent check. The molar absorption coefficient can be estimated from residue counts: 5,500 M⁻¹ cm⁻¹ per Trp, 1,490 per Tyr and 125 per cystine. Those values were derived from folded proteins, and their authors advise measuring rather than predicting where accuracy matters (Pace et al., 1995).

Identity: what a mass spectrum confirms

An intact mass does not confirm residue order. Any rearrangement of the same residues, a scrambled control included, has exactly the same mass, and leucine and isoleucine are isobaric. Tandem MS fragments the backbone into ion series that read out the sequence (Steen & Mann, 2004), although those backbone ions still cannot tell leucine from isoleucine. For a new sequence, a new supplier or an unexpected result, MS/MS is the stronger evidence.

Further reading from our research series

Research use only. This article summarises published scientific literature for laboratory researchers. OP Labs (RFR Global Ltd) products are supplied for in-vitro laboratory research only. They are not licensed medicines and are not for human or veterinary use.

References

  1. Geiger, T. & Clarke, S. (1987). Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. Journal of Biological Chemistry, 262(2), 785–794. https://doi.org/10.1016/S0021-9258(19)75855-4
  2. Mant, C. T., Chen, Y., Yan, Z., Popa, T. V., Kovacs, J. M., Mills, J. B., Tripet, B. P. & Hodges, R. S. (2007). HPLC analysis and purification of peptides. In G. B. Fields (Ed.), Peptide Characterization and Application Protocols (Methods in Molecular Biology, vol. 386, pp. 3–55). https://doi.org/10.1007/978-1-59745-430-8_1
  3. Mascagni, P. (1999). Purification of large peptides using chemoselective tags. In Fmoc Solid Phase Peptide Synthesis. Oxford University Press. https://doi.org/10.1093/oso/9780199637256.003.0016
  4. Melanson, J. E., Thibeault, M.-P., Stocks, B. B., Leek, D. M., McRae, G. & Meija, J. (2018). Purity assignment for peptide certified reference materials by combining qNMR and LC-MS/MS amino acid analysis results: application to angiotensin II. Analytical and Bioanalytical Chemistry, 410(26), 6719–6731. https://doi.org/10.1007/s00216-018-1272-7
  5. Mergler, M., Dick, F., Sax, B., Weiler, P. & Vorherr, T. (2003). The aspartimide problem in Fmoc-based SPPS. Part I. Journal of Peptide Science, 9(1), 36–46. https://doi.org/10.1002/psc.430
  6. Pace, C. N., Vajdos, F., Fee, L., Grimsley, G. & Gray, T. (1995). How to measure and predict the molar absorption coefficient of a protein. Protein Science, 4(11), 2411–2423. https://doi.org/10.1002/pro.5560041120
  7. Sikora, K., Jaśkiewicz, M., Neubauer, D., Migoń, D. & Kamysz, W. (2020). The role of counter-ions in peptides—an overview. Pharmaceuticals, 13(12), 442. https://doi.org/10.3390/ph13120442
  8. Stadtman, E. R. & Levine, R. L. (2003). Free radical-mediated oxidation of free amino acids and amino acid residues in proteins. Amino Acids, 25(3–4), 207–218. https://doi.org/10.1007/s00726-003-0011-2
  9. Steen, H. & Mann, M. (2004). The abc’s (and xyz’s) of peptide sequencing. Nature Reviews Molecular Cell Biology, 5(9), 699–711. https://doi.org/10.1038/nrm1468

One comment

  1. […] The Number That Decides If a Peptide Is RealHow purity is measured — and why it matters for any research peptide. […]

Comments are closed.

Same Day Dispatch.

On orders placed before 16:00.

Customer Support.
International Shipping.

To selected countries.